These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 932491)

  • 1. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic response to revaccination with two rubella vaccines.
    Brandling-Bennett AD; Jackson RS; Halstead SB; Campbell CC; Herrmann KL; Modlin JF; Meyers JD; Witte JJ
    Am J Dis Child; 1976 Oct; 130(10):1081-4. PubMed ID: 973610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to experimental challenge in persons immunized with different rubella vaccines.
    Fogel A; Gerichter CB; Barnea B; Handsher R; Heeger E
    J Pediatr; 1978 Jan; 92(1):26-9. PubMed ID: 619075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA; Heywood SN; Laughton E; Gould JJ; Freestone DS
    J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.
    Schluederberg A; Horstmann DM; Andiman WA; Randolph MF
    J Infect Dis; 1978 Dec; 138(6):877-83. PubMed ID: 105058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubella immunization. Persistence of antibody four years after a large-scale field trial.
    Herrmann KL; Halstead SB; Brandling-Bennett AD; Witte JJ; Wiebenga NH; Eddins DL
    JAMA; 1976 May; 235(20):2201-4. PubMed ID: 946844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge.
    Harcourt GC; Best JM; Banatvala JE
    J Infect Dis; 1980 Aug; 142(2):145-55. PubMed ID: 7410897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological response to rubella revaccination.
    Serdula MK; Halstead SB; Wiebenga NH; Herrmann KL
    JAMA; 1984 Apr; 251(15):1974-7. PubMed ID: 6700099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evaluation of the optimum age for rubella vaccine administration.
    Wilkins J; Wehrle PF
    Am J Dis Child; 1979 Dec; 133(12):1237-9. PubMed ID: 517472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
    Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA
    Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubella antibody persistence after immunization.
    Herrmann KL; Halstead SB; Wiebenga NH
    JAMA; 1982 Jan; 247(2):193-6. PubMed ID: 7053457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley.
    Freestone DS; Reynolds GM; McKinnon JA; Prydie J
    Br J Prev Soc Med; 1975 Dec; 29(4):258-61. PubMed ID: 766879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubella-vaccinated students. Follow-up in a public school system.
    Schiff GM; Rauh JL; Young B; Trimble S; Rotte T; Schiff BE
    JAMA; 1978 Dec; 240(24):2635-7. PubMed ID: 712979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling rubella: problems and perspectives.
    Horstmann DM
    Ann Intern Med; 1975 Sep; 83(3):412-7. PubMed ID: 1180441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.
    Grillner L
    Scand J Infect Dis; 1975; 7(3):169-72. PubMed ID: 1237176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenge with rubella virus after loss of detectable vaccine-induced antibody.
    Schiff GM; Young BC; Stefanovic' GM; Stamler EF; Knowlton DR; Grundy BJ; Dorsett PH
    Rev Infect Dis; 1985; 7 Suppl 1():S157-63. PubMed ID: 4001723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.